This result indicates that DNMT3A is required for hypoxia-mediated EMT process in multiple types of cancer cells through the binding of HIF-1α to the proximal promoter region and consequent activation of the EMT-associated TWIST1 gene. The gene discussed is TWIST1; the disease is cancer.